Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Storkus

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokinesC C Wilson, W C Olson, T Tuting, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1995
Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytesM J Maeurer, D M Martin, C Castelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cellsK Chikamatsu, K Nakano, W J Storkus, et al.
Cancer Research|January 1, 1995
Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyteM A Frassanito, J I Mayordomo, R M DeLeo, et al.
Cancer Gene Therapy|July 13, 2013
Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cellsL Chen, J L Taylor, N C Sabins, et al.
European Journal of Immunology|November 1, 1996
Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytesM J Maeurer, H W Chan, J Karbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995
Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblastsL Zitvogel, H Tahara, P D Robbins, et al.
Cancer Gene Therapy|May 16, 2009
Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunityH Komita, X Zhao, A K Katakam, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1991
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2W J Storkus, R D Salter, J Alexander, et al.
The Journal of Experimental Medicine|January 1, 1996
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokinesL Zitvogel, J I Mayordomo, T Tjandrawan, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokinesC C Wilson, W C Olson, T Tuting, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1995
Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytesM J Maeurer, D M Martin, C Castelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cellsK Chikamatsu, K Nakano, W J Storkus, et al.
Cancer Research|January 1, 1995
Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyteM A Frassanito, J I Mayordomo, R M DeLeo, et al.
Cancer Gene Therapy|July 13, 2013
Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cellsL Chen, J L Taylor, N C Sabins, et al.
European Journal of Immunology|November 1, 1996
Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytesM J Maeurer, H W Chan, J Karbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995
Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblastsL Zitvogel, H Tahara, P D Robbins, et al.
Cancer Gene Therapy|May 16, 2009
Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunityH Komita, X Zhao, A K Katakam, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1991
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2W J Storkus, R D Salter, J Alexander, et al.
The Journal of Experimental Medicine|January 1, 1996
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokinesL Zitvogel, J I Mayordomo, T Tjandrawan, et al.
Pageof 8